Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE254101 |
A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins
|
|
28 | Dominik Niopek | Mar 01, 2024 | |||
GSE230526 |
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma
|
90 | Yinghui Li | Mar 01, 2024 | ||||
GSE230292 |
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma [HICHIP]
|
2 | Yinghui Li | Mar 01, 2024 | ||||
GSE214438 |
Age-associated chromatin re-organization in progenitor B cells
|
76 | Yaqiang Cao | Mar 01, 2024 | ||||
GSE235534 |
BRG1 establishes the neuroectodermal chromatin landscape to restrict dorsal cell fates
|
41 | Jackson Andrew Hoffman | Mar 01, 2024 | ||||
GSE254334 |
CRISPR Screen identifies regulators for T cells activities in pancreatic cancer
|
|
2 | Richard Lin | Mar 01, 2024 | |||
GSE214105 |
Cerebral organoids display dynamic clonal growth with lineage replenishment
|
9 | Simon Emanuel Haendeler | Mar 01, 2024 | ||||
GSE198936 |
Comparative cofactor screens reveal the influence of transactivation domains and core promoters on the mechanisms of transcription [CRISPR TAD]
|
|
64 | Charles C Bell | Mar 01, 2024 | |||
GSE256168 |
Comparative cofactor screens reveal the influence of transactivation domains and core promoters on the mechanisms of transcription [CRISPR promoter]
|
|
54 | Charles C Bell | Mar 01, 2024 | |||
GSE256174 |
Comparative cofactor screens reveal the influence of transactivation domains and core promoters on the mechanisms of transcription [ZFP-TAD]
|
|
6 | Charles C Bell | Mar 01, 2024 | |||
GSE198944 |
Comparative cofactor screens reveal the influence of transactivation domains and core promoters on the mechanisms of transcription.
|
165 | Charles C Bell | Mar 01, 2024 | ||||
GSE225043 |
Early measurable residual disease dynamics and B cell receptor reconstitution following venetoclax and obinutuzumab in chronic lymphocytic leukemia
|
|
227 | Paul Hengeveld | Mar 01, 2024 | |||
GSE169555 |
Embryonic lumenogenesis is controlled by selective mRNA decay triggered by LIN28A relocation
|
146 | Jernej Ule | Mar 01, 2024 | ||||
GSE169547 |
Embryonic lumenogenesis is controlled by selective mRNA decay triggered by LIN28A relocation [iCLIP]
|
20 | Jernej Ule | Mar 01, 2024 | ||||
GSE169549 |
Embryonic lumenogenesis is controlled by selective mRNA decay triggered by LIN28A relocation [miCLIP]
|
3 | Jernej Ule | Mar 01, 2024 | ||||
GSE254843 |
Experimental tests strongly challenge the evidence of a healthy human blood microbiome
|
|
15 | Matteo Ramazzotti | Mar 01, 2024 | |||
GSE256462 |
GAS41 modulates ferroptosis by anchoring NRF2 on chromatin
|
|
2 | Xin Yang | Mar 01, 2024 | |||
GSE226533 |
Human and Murine Kidneys Contain Transcriptionally and Spatially Orthologous Resident Macrophage Subpopulations in Acute Kidney Injury
|
4 | James F George | Mar 01, 2024 | ||||
GSE243776 |
Identification and targeting of extremely high-risk gamma delta T-ALL in children
|
69 | QINGSONG GAO | Mar 01, 2024 | ||||
GSE228657 |
Isolation of biologically active small peptide from KSHV LANA protein sequence, which induces CHD4 degradation to promote cell differentiation and inhibits leukemic cell growth
|
30 | Clifford G. Tepper | Mar 01, 2024 |